HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].

Abstract
A 32-year-old male patient was admitted at our department presenting microhematuria and full nephrotic syndrome in April 1995. A percutaneous kidney biopsy showed a stage I-lI membranous nephropathy and an eight-week course with oral prednisone was initiated without response. Then, oral cyclosporine A (3.5 mg/kg/day) was given and after 5 weeks of treatment, remission of the nephrotic syndrome was observed but creatinine raised to 1.6 mg/dl, normalizing after reducing the dose of cyclosporine A. We discuss the settings, prognostic and therapeutic alternatives for idiopathic membranous nephropathy.
AuthorsA B Muñoz Díaz, P Aguilar
JournalNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia (Nefrologia) Vol. 24 Suppl 3 Pg. 76-80 ( 2004) ISSN: 0211-6995 [Print] Spain
Vernacular TitleNefropatía membranosa idiopática asociada a toxicidad por anticalcineurínicos.
PMID15219075 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Calcineurin Inhibitors
  • Calcium Channel Blockers
  • Hypolipidemic Agents
  • Immunosuppressive Agents
  • Cyclosporine
  • Lovastatin
  • Creatinine
  • Verapamil
  • Lisinopril
  • Prednisone
Topics
  • Adult
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Antihypertensive Agents (therapeutic use)
  • Calcineurin Inhibitors
  • Calcium Channel Blockers (therapeutic use)
  • Creatinine (blood)
  • Cyclosporine (adverse effects, therapeutic use)
  • Drug Therapy, Combination
  • Glomerulonephritis, Membranous (complications)
  • Humans
  • Hypercholesterolemia (complications, drug therapy)
  • Hypertension (complications, drug therapy)
  • Hypolipidemic Agents (therapeutic use)
  • Immunosuppressive Agents (adverse effects, therapeutic use)
  • Kidney Diseases (chemically induced)
  • Lisinopril (therapeutic use)
  • Lovastatin (therapeutic use)
  • Male
  • Nephrotic Syndrome (drug therapy, etiology)
  • Prednisone (therapeutic use)
  • Recurrence
  • Verapamil (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: